Dong-A ST (KRX:170900) posted a year-over-year profit in net income from continuing operations of 11 billion won in the second quarter, from a loss of 22.4 billion won.
Sales of the pharmaceutical firm jumped 17% to 207.8 billion won from 177.4 billion won, according to a Tuesday filing with the Korea Exchange.